Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Integrin
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Abegrin
(etaracizumab) / AstraZeneca
volociximab
(M200) / AbbVie, Biogen
abituzumab
(EMD 525797) / EMD Serono, SFJ Pharma
bexotegrast
(PLN-74809) / Pliant Therapeutics
firategrast
(SB683699) / GSK
Ossirene
(AS101) / Feramda, Cosmo Pharma
E7820
/ Eisai
Luminate
(risuteganib) / Allegro Ophthalmics
MORF-057
/ Morphic Therap
abrilumab
(AMG 181) / Amgen, AstraZeneca
vatelizumab
(GBR 500) / Glenmark
BG00011
/ Biogen
milategrast
(E6007) / Eisai
GS-1427
/ Gilead
OTT166
/ OcuTerra Therap
PTG-100
/ Protagonist Therap
intetumumab
(CNTO 95) / J&J
ABBV-382
/ AbbVie
AMEP BA 015
/ Valerio Therap
ASP5094
/ Astellas
GB1275
/ Gossamer Bio
SAN-300
/ Bausch Health
THR-687
/ Oxurion
AXR-159
/ AxeroVision
Lutetium-177-PEG-αvβ3-IAC
/ Advanced Innovative Partners
OPC-415
/ Otsuka
PN-943
/ Protagonist Therap
TRK-170
/ Toray
VPI-2690B
/ Vascular Pharma
